FIELD: biotechnology, immunology. SUBSTANCE: gold colloidal solution is used as an adjuvant. Invention provides reducing toxicity of vaccines, to enhance their immunogenic activity and to provide stability of vaccine in storage. EFFECT: improved and valuable properties of adjuvant. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
ADJUVANT FOR BIOPREPARATIONS | 2002 |
|
RU2214278C1 |
IMMUNOGENIC COMPOSITION | 2005 |
|
RU2308289C2 |
RUBELLA VACCINE ON THE BASIS OF A STRUCTURALLY-MODIFIED VIRUS OF PLANTS AND A METHOD FOR ITS PRODUCTION | 2016 |
|
RU2660563C2 |
VACCINE AGAINST VIRAL INFECTIONS | 2000 |
|
RU2217162C2 |
ANTIGEN CARRIER AND ADJUVANT | 2006 |
|
RU2311926C2 |
IMMUNOGENIC COMPOSITIONS OF Bordetella bronchiseptica | 2012 |
|
RU2554480C2 |
IMMUNOGENIC COMPOSITION, CONTAINING FOREIGN ANTIGENS ON SURFACE OF SPHERICAL CARRIERS, OBTAINED BY THERMAL DENATURATION OF SPIRAL VIRUSES | 2010 |
|
RU2440140C1 |
COMPOSITION AND METHOD FOR CONTROLLED RELEASING OF INJECTION SOLUTIONS | 2002 |
|
RU2313366C2 |
VACCINE COMPOSITION AGAINST HEPATITIS, A METHOD OF HEPATITIS PROPHYLAXIS | 1993 |
|
RU2121849C1 |
IMMUNOGENIC SUBSTANCES CONTAINING ADJUVANT OF POLYINOSINE ACID AND POLYCYTIDYLIC ACID | 2006 |
|
RU2462264C2 |
Authors
Dates
2003-12-20—Published
2001-12-13—Filed